How many studies have been conducted on Sulfasalazine?

BiohacksAI has indexed 296 PubMed studies on Sulfasalazine, including 27 randomized controlled trials (RCTs). 41% of studies involve human subjects.

What are the main research areas for Sulfasalazine?

The primary research domains for Sulfasalazine are 🔬 Inflammation, 🦴 Bone & Joint, 🔬 Oncology. This is based on analysis of 296 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Sulfasalazine

A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)

296+ PubMed studies analyzed · 27 RCTs · Evidence Score: 47.5

Research Domains

Sulfasalazine has been studied across 19 research domains including 🔬 Inflammation, 🦴 Bone & Joint, 🔬 Oncology, 🦠 Gut & Microbiome, 🫁 Liver & Detox. The primary research focus is 🔬 Inflammation with 30% of studies addressing this area.

Loading evidence profile...

This evidence profile for Sulfasalazine is generated deterministically from 296 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.